Who
Philip Rackliffe
CEO, Ais
Company insider
Files Form 4 as: CEO, Ais, GE HealthCare Technologies.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $79K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Aug 2024
- Last trade
- 3 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Sep 2026filed 4 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $56K798 at $70.56 | filing |
| 3 Sep 2026filed 4 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $56K798 at $70.56 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $21K290 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $16K226 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $24K340 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $21K290 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $16K226 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $24K340 at $71.23 | filing |
| 15 May 2026filed 19 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —16,458 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —16,458 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —9,356 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —24,598 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —24,598 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —9,356 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —3,154 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $93K1,174 at $79.20 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —3,154 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $93K1,174 at $79.20 | filing |
| 1 Feb 2026filed 3 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $15K189 at $78.97 | filing |
| 1 Feb 2026filed 3 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $15K189 at $78.97 | filing |
News
Analyzing GE HealthCare Technologies (NASDAQ:GEHC) & AxoGen (NASDAQ:AXGN)GEHC · tickerreport.com · 21 Oct 2026Stock Traders Buy High Volume of Call Options on GE HealthCare Technologies (NASDAQ:GEHC)GEHC · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Philip Rackliffe; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.